Full-Time
Updated on 1/15/2025
Develops monoclonal antibodies for infectious diseases
$203.5k - $284kAnnually
Expert
No H1B Sponsorship
San Francisco, CA, USA
Requires onsite presence in San Francisco for four days per week.
Vir Biotechnology develops treatments for infectious diseases by leveraging the immune system. They use a platform that combines monoclonal antibodies with machine learning to create a database of human antibodies, which helps in designing effective medicines. Their projects include therapies for hepatitis B, HIV, and COVID-19, as well as a T cell vaccine for HIV prevention. Vir stands out by integrating AI in drug development, aiming to transform lives through innovative treatments.
Company Stage
IPO
Total Funding
$640.6M
Headquarters
San Francisco, California
Founded
2016
Help us improve and share your feedback! Did you find this helpful?
Comprehensive healthcare coverage
Employer matched 401(k)
Employee stock purchase plan
Childcare assistance
Tuition reimbursement